Prognostic and clinicopathological significance of Fusobacterium nucleatum in colorectal cancer: a systemic review and meta-analysis
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Fusobacterium nucleatum has been identified to promote tumor progression in colorectal cancer (CRC). However, association between F. nucleatum and prognostic or clinicopathological features has been diverse among studies, which could be affected by type of biospecimen (formalin-fixed paraffin-embedded or fresh frozen [FF]). Methods: Articles were systemically reviewed for studies that included the correlation between F. nucleatum and prognosis or clinicopathological features in CRC. Results: Ten articles, eight studies with survival-related features involving 3,199 patients and nine studies with clinical features involving 2,655 patients, were eligible for the meta-analysis. Overall survival, disease-free survival, and cancer-specific survival were all associated with worse prognosis in F. nucleatum–high patients (p < .05). In subgroup analysis, only studies with FF tissues retained prognostic significance with F. nucleatum. In meta-analysis of clinicopathological variables, F. nucleatum level was associated with location within colon, pT category, MLH1 hypermethylation, microsatellite instability status, and BRAF mutation regardless of type of biospecimen. However, lymph node metastasis and KRAS mutation was only associated with F. nucleatum level in FF-based studies. Conclusions: In conclusion, type of biospecimen could affect the role of F. nucleatum as a biomarker associated with clinicopathological features and prognosis.
Abstract
Background: Fusobacterium nucleatum has been identified to promote tumor progression in colorectal cancer (CRC). However, association between F. nucleatum and prognostic or clinicopathological features has been diverse among studies, which could be affected by type of biospecimen (formalin-fixed paraffin-embedded or fresh frozen [FF]). Methods: Articles were systemically reviewed for studies that included the correlation between F. nucleatum and prognosis or clinicopathological features in CRC. Results: Ten articles, eight studies with survival-related features involving 3,199 patients and nine studies with clinical features involving 2,655 patients, were eligible for the meta-analysis. Overall survival, disease-free survival, and cancer-specific survival were all associated with worse prognosis in F. nucleatum–high patients (p < .05). In subgroup analysis, only studies with FF tissues retained prognostic significance with F. nucleatum. In meta-analysis of clinicopathological variables, F. nucleatum level was associated with location within colon, pT category, MLH1 hypermethylation, microsatellite instability status, and BRAF mutation regardless of type of biospecimen. However, lymph node metastasis and KRAS mutation was only associated with F. nucleatum level in FF-based studies. Conclusions: In conclusion, type of biospecimen could affect the role of F. nucleatum as a biomarker associated with clinicopathological features and prognosis.
참고문헌 (34)
- Wu Y, "Fusobacterium nucleatum potentiates intestinal tumorigenesis in mice via a Toll-like receptor 4", p21-activated kinase 1 cascade, 2018, pp.63, 1210~1218
- Kostic AD, "Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment", Cell Host Microbe, 14, pp.207~215 (2013)
- Marchesi JR, "The gut microbiota and host health : a new clinical frontier", Gut, 65, pp.330~339 (2016)
- Kostic AD, "Genomic analysis identifies association of Fusobacterium with colorectal carcinoma", Genome Res, 22, pp.292~298 (2012)
- Castellarin M, "Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma", Genome Res, 22, pp.299~306 (2012)
- Ito M, "Association of Fusobacterium nucleatum with clinical and molecular features in colorectal serrated pathway", Int J Cancer, 137, pp.1258~1268 (2015)
- McCoy AN, "Fusobacterium is associated with colorectal adenomas", PLoS One, 8, pp.e53653~ (2013)
- Rubinstein MR, "Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin", beta-catenin signaling via its FadA adhesin, 2013, pp.14, 195~206
- Abed J, "Fap2 mediates Fusobacterium nucleatum colorectal adenocarcinoma enrichment by binding to tumor-expressed Gal-GalNAc", Cell Host Microbe, 20, pp.215~225 (2016)
- Yang Y, "Fusobacterium nucleatum increases proliferation of colorectal cancer cells and tumor development in mice by activating Toll-like receptor 4 signaling to nuclear factorkappaB, and up-regulating expression of microRNA-21", Gastroenterology, 152, pp.851~866 (2017)
- Yu T, "Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy", Cell, 170, pp.548~563 (2017)
- Mandip KC, "Novel mechanisms of chemoresistance by Fusobacterium nucleatum involve not so novel pathways of microRNAs and autophagy", Transl Cancer Res, 7(Suppl 1), pp.S10~S15 (2018)
- Bullman S, "Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer", Science, 358, pp.1443~1448 (2017)
- Wei Z, "Could gut microbiota serve as prognostic biomarker associated with colorectal cancer patients’ survival? A pilot study on relevant mechanism", Oncotarget, 7, pp.46158~46172 (2016)
- Yamaoka Y, "Fusobacterium nucleatum as a prognostic marker of colorectal cancer in a Japanese population", J Gastroenterol, 53, pp.517~524 (2018)
- Yan X, "Clinical significance of Fusobacterium nucleatum, epithelial-mesenchymal transition, and cancer stem cell markers in stage III", IV colorectal cancer patients, 2017, pp.10, 5031~5046
- 오현정, "Prognostic Impact of Fusobacterium nucleatum Depends on Combined Tumor Location and Microsatellite Instability Status in Stage II", III Colorectal Cancers Treated with Adjuvant Chemotherapy, 2019, pp.53(1), 40~49[DOI]
- Sakamoto Y, "Fusobacterium nucleatum in colorectal cancer liver metastasis and patient prognosis", Cancer Sci, 109, pp.1360~ (2018)
- Chernyavskiy P, "Heterogeneity of colon and rectum cancer incidence across 612SEER counties, 2000-2014", Int J Cancer, 144, pp.1786~1795 (2019)
- de Carvalho AC, "Microbiota profile and impact of Fusobacterium nucleatum in colorectal cancer patients of Barretos Cancer Hospital", Front Oncol, 9, pp.813~ (2019)
- Tierney JF, "Practical methods for incorporating summary time-to-event data into metaanalysis", Trials, 8, pp.16~ (2007)
- Sun Y, "Fusobacterium nucleatum infection is correlated with tumor metastasis and postoperative survival of colorectal cancer patients in China", Transl Cancer Res, 5, pp.579~588 (2016)
- Kunzmann AT, "Fusobacterium nucleatum tumor DNA levels are associated with survival in colorectal cancer patients", Eur J Clin Microbiol Infect Dis, 38, pp.1891~1899 (2019)
- Chen Y, "Prognostic impact of the Fusobacterium nucleatum status in colorectal cancers", Medicine(Baltimore), 98, pp.e17221~ (2019)
- Mima K, "Fusobacterium nucleatum and T cells in colorectal carcinoma", JAMA Oncol, 1, pp.653~661 (2015)
- Chen Y, "Fusobacterium nucleatum promotes metastasis in colorectal cancer by activating autophagy signaling via the upregulation of CARD3 expression", Theranostics, 10, pp.323~339 (2020)
- Wang S, "Fusobacterium nucleatum acts as a procarcinogenic bacterium in colorectal cancer : from association to causality", Front Cell Dev Biol, 9, pp.710165~ (2021)
- Zhang S, "Fusobacterium nucleatum promotes chemoresistance to 5-fluorouracil by upregulation of BIRC3expression in colorectal cancer", J Exp Clin Cancer Res, 38, pp.14~ (2019)
- Bae JM, "Molecular subtypes of colorectal cancer and their clinicopathologic features, with an emphasis on the serrated neoplasia pathway", Arch Pathol Lab Med, 140, pp.406~412 (2016)
- Wen X, "Improved results of LINE-1 methylation analysis in formalin-fixed, paraffin-embedded tissues with the application of a heating step during the DNA extraction process", Clin Epigenetics, 9, pp.1~ (2017)
- Freifelder D, "Physicochemical studies on the reaction between formaldehyde and DNA", Biophys J, 3, pp.49~63 (1963)
- Imrit K, "Identification of bacteria in formalin-fixed, paraffin-embedded heart valve tissue via 16S rRNA gene nucleotide sequencing", J Clin Microbiol, 44, pp.2609~2611 (2006)
- Gethings-Behncke C, "Fusobacterium nucleatum in the colorectum and its association with cancer risk and survival : a systematic review and meta-analysis", Cancer Epidemiol Biomarkers Prev, 29, pp.539~548 (2020)
- Huangfu SC, "Clinicopathological and prognostic significance of Fusobacterium nucleatum infection in colorectal cancer : a meta-analysis", J Cancer, 12, pp.1583~1591 (2021)